查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576920

神經補綴的全球市場:洞察，競爭情形，市場預測:2030年

Neuroprosthetics - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年神經修復術的市場規模為71.4億美元。預計到 2030 年，該市場將達到 146.4 億美元，2024 年至 2030 年的預測期間複合年增長率為 12.75%。神經假體的需求主要是由於神經系統疾病和損傷的盛行率不斷上升，以及患有聽力損失和視力喪失的患者數量不斷增加。主要公司之間的研發活動以及先進設備開發合作的發展是2024-2030年預測期內神經義肢市場積極成長的主要因素。

神經系統疾病和損傷盛行率的上升預計將推動神經修復市場的顯著成長。根據世界衛生組織（WHO）2024年4月發布的數據，2021年全球約有1540萬人遭受脊髓損傷。同樣，美國脊椎協會報告稱，到 2022 年，美國每年將有約 17,700 人被診斷出患有脊髓損傷。透過刺激肌肉和神經來恢復運動功能的神經修復術對於遭受此類傷害的人來說變得極為重要。隨著神經系統疾病，特別是脊髓損傷的發生率增加，對神經修復解決方案的需求也增加，加速了市場擴張。

肌萎縮側索硬化症（ALS）和脊髓性肌萎縮症等運動神經元疾病以及阿茲海默症和帕金森氏症等認知障礙的發病率不斷增加，預計將進一步推動市場成長。根據世界衛生組織在 2023 年發布的估計，全球約有 5500 萬人患有癡呆症，每年報告近 1000 萬新病例。阿茲海默症是最常見的失智症，佔這些病例的 60-70%。隨著運動神經元疾病患者數量持續增加，對神經假體的需求預計將激增，市場預計將在預測期內取得重大進展。

此外，對神經假體的需求也延伸到聽力和視力障礙等感覺障礙。根據世界衛生組織2023年3月的數據，歐洲有超過1.9億人受到聽力損失的影響，預計2050年將增加至超過2.3億人。人工耳蝸是一種典型的神經假體，透過繞過內耳受損部分，直接刺激聽神經，對重度感音神經性聽力損失患者的聽力恢復發揮重要作用。隨著聽力和視力障礙變得更加普遍，神經修復市場預計將出現強勁成長。

本報告提供全球神經補綴市場相關調查，提供市場概要，以及各類型，手術，各技術，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 神經補綴市場報告的簡介

第2章 神經補綴市場摘要整理

第3章 競爭情形

第4章 法規分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 神經補綴市場主要原因分析

  • 神經補綴的市場促進因素
  • 神經補綴的市場阻礙因素與課題
  • 神經補綴的市場機會

第6章 神經補綴市場上波特的五力分析

第7章 神經補綴市場評估

  • 各類型
  • 各手術
  • 各技術
  • 各終端用戶
  • 各地區

第8章 神經補綴市場企業與產品簡介

  • Medtronic
  • Boston Scientific Corporation
  • Abbott Laboratories
  • NeuroPace, Inc.
  • Cochlear Ltd.
  • Sonova
  • NeuroSigma, Inc.
  • Blackrock Neurotech
  • Synchron
  • LivaNova, Inc.
  • MED-EL Medical Electronics
  • BrainGate
  • NEVRO CORP.
  • Terumo Corporation
  • Penumbra, Inc.
  • BrainCo, Inc.
  • Axoft Inc.
  • Demant A/S
  • Synapse Biomedical Inc.
  • Cognixion, Inc.

第9章 KOL的見解

第10章 計劃的方法

第11章 關於DelveInsight

第12章 免責聲明和諮詢方式

Product Code: DIMDCL0034

Neuroprosthetics Market by Type (Motor Prosthetics, Cognitive Prosthetics, Auditory Prosthetics/Cochlear Implants, and Visual Prosthetics/Retinal Implants), Procedure (Invasive and Non-Invasive), Technology (Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing the growing prevalence of neurological disorders and increasing R&D activities and collaborations to develop advanced devices.

The neuroprosthetics market was valued at USD 7.14 billion in 2023, growing at a CAGR of 12.75% during the forecast period from 2024 to 2030, to reach USD 14.64 billion by 2030. The demand for neuroprosthetics is primarily attributed to the growing prevalence of neurological disorders and nerve injuries and the rising number of patients suffering from hearing and vision loss. Increasing R&D activities and collaborations to develop advanced devices among key players are the key factors that are responsible in contributing to the positive growth of the neuroprosthetics market during the forecast period from 2024 to 2030.

Neuroprosthetics Market Dynamics:

The increasing prevalence of neurological disorders and nerve injuries is poised to drive significant growth in the neuroprosthetics market. According to data released by the World Health Organization (WHO) in April 2024, approximately 15.4 million people worldwide were living with spinal cord injuries in 2021. Similarly, the United Spinal Association reported in 2022 that around 17,700 individuals are diagnosed with spinal cord injuries annually in the United States. Neuroprosthetic devices, which restore motor function by stimulating muscles or nerves, have become crucial for individuals affected by such injuries. As the incidence of neurological conditions, especially spinal cord injuries, rises, so does the demand for neuroprosthetic solutions, accelerating market expansion.

The growing occurrence of motor neuron disorders, including amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy, as well as cognitive disorders such as Alzheimer's and Parkinson's disease, is expected to further boost market growth. WHO estimates from 2023 show that approximately 55 million people worldwide were living with dementia, with nearly 10 million new cases being reported annually. Alzheimer's disease, the most common form of dementia, accounts for 60-70% of these cases. As the number of patients with motor neuron disorders continues to rise, the need for neuroprosthetics is projected to surge, driving substantial advancements in the market over the forecast period.

Furthermore, the demand for neuroprosthetics extends to sensory impairments, such as hearing and vision loss. WHO data from March 2023 indicates that over 190 million people in Europe were affected by hearing loss, a number expected to exceed 230 million by 2050. Cochlear implants, a leading type of neuroprosthetic device, play a key role in restoring hearing for individuals with severe sensorineural hearing loss by bypassing damaged parts of the inner ear and directly stimulating the auditory nerve. As hearing and vision impairments become more prevalent, the neuroprosthetics market is expected to experience robust growth.

Source: World Health Organization, 2023

In addition to rising patient numbers, increasing research and development initiatives are expected to fuel further market expansion. For example, in April 2021, Rice University and Houston Methodist launched the Center for Translational Neural Prosthetics, focusing on restoring brain functions lost due to disease or injury.

However, certain challenges, such as the high cost of these devices and the lack of proper training in underdeveloped regions, may constrain market growth. Addressing these barriers will be key to unlocking the full potential of neuroprosthetic technologies.

Neuroprosthetics Market Segment Analysis:

Neuroprosthetics Market by Type (Motor Prosthetics, Cognitive Prosthetics, Auditory Prosthetics/Cochlear Implants, and Visual Prosthetics/Retinal Implants), Procedure (Invasive and Non-Invasive), Technology (Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

The spinal cord stimulation (SCS) segment is expected to hold a prominent position in the neuroprosthetics market during the forecast period, driven by the rising prevalence of chronic pain conditions, including complex regional pain syndrome (CRPS) and spinal cord injuries. With an increasing number of patients affected by failed back syndrome and CRPS, demand for SCS technology is set to grow significantly. Research has consistently demonstrated that SCS is an effective treatment for managing patients with CRPS. According to 2023 data from the National Organization for Rare Disorders, approximately 200,000 individuals in the United States are affected by CRPS annually. As the prevalence of both CRPS and spinal cord injuries continues to rise, the demand for SCS devices is increasing, thereby contributing to substantial market growth.

Recent regulatory approvals for SCS technology are further expected to propel the neuroprosthetics market. For example, in April 2024, Medtronic received approval from the U.S. Food and Drug Administration (FDA) for its Inceptiv(TM) closed-loop rechargeable spinal cord stimulator, designed to treat chronic pain. This advanced device features a closed-loop system that senses biological signals along the spinal cord, ensuring consistent delivery of physician-prescribed stimulation for improved patient outcomes. Such technological advancements from key industry players are anticipated to drive continued growth in the market.

North America is expected to dominate the overall neuroprosthetics market:

North America is projected to dominate the global neuroprosthetics market during the forecast period, primarily driven by the rising prevalence of hearing loss and neurological disorders such as Alzheimer's disease, Parkinson's disease, and depression. Additionally, increasing healthcare awareness and ongoing technological advancements from leading industry players are significantly boosting market growth in this region.

A key factor driving market expansion in North America is the growing incidence of neurological disorders. According to a report from the Centers for Disease Control and Prevention (CDC) in September 2023, approximately 6.7 million individuals aged 65 and older in the United States were living with Alzheimer's disease, with that number expected to rise to 13.9 million by 2060. The escalating prevalence of such conditions is fueling demand for neuroprosthetic devices, thereby propelling market growth.

The growing burden of hearing loss is also contributing to the region's market expansion. CDC data from November 2023 revealed that in 2021, there were 6,520 reported cases of permanent hearing loss in the United States. This rising incidence is further driving the adoption of neuroprosthetic solutions, such as cochlear implants, to address sensory impairments.

Technological innovation by key players is another factor supporting North America's market dominance. For example, in November 2022, U.S.-based brain-computer interface company Blackrock Neurotech introduced Neuralace(TM), a next-generation neural interface. This advanced device, designed with diverse materials and patterns, connects with large areas of the brain's surface, enabling complex functions without the need for external assistive technologies. Neuralace offers groundbreaking solutions for vision and memory restoration, performance prediction, and the treatment of mental health disorders, underscoring the role of innovation in driving market growth.

Meanwhile, the Asia-Pacific region holds significant growth potential for the neuroprosthetics market. This expansion can be attributed to improving healthcare infrastructure, rising disposable incomes, and increasing incidences of hearing loss. According to a 2021 report from the World Health Organization (WHO), around 80% of people with disabling hearing loss reside in low- and middle-income countries, with over 25% of individuals aged 60 and older affected. As the region's economies develop and healthcare systems improve, the demand for neuroprosthetic devices is expected to rise, fueling further market growth in Asia-Pacific.

Neuroprosthetics Market Key Players:

Some of the key market players operating in the neuroprosthetics market include Medtronic, Boston Scientific Corporation, Abbott Laboratories, NeuroPace, Inc., Cochlear Ltd., Sonova, NeuroSigma, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., MED-EL Medical Electronics, BrainGate, NEVRO CORP., Terumo Corporation, Penumbra, Inc., BrainCo, Inc., Axoft Inc., Demant A/S, Synapse Biomedical Inc., Cognixion, Inc., and others.

Recent Developmental Activities in the Neuroprosthetics Market:

  • In February 2024, Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) approved the WaveWriter(TM) SCS Systems for the treatment of chronic low back and leg pain. This system assists physicians in delivering individualized care for a broad range of lower back pain issues, allowing for tailored treatment strategies to address diverse patient needs.
  • In January 2024, Abbott Laboratories announced that it granted FDA approval to market the Liberta RC(TM) DBS system. Liberta is the smallest rechargeable deep brain stimulation (DBS) device equipped with remote programming capabilities, designed to treat individuals with movement disorders such as Parkinson's disease and essential tremor.
  • In March 2021, Second Sight Medical Products, a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, received the US Food and Drug Administration (FDA) approval for the Argus 2s Retinal Prosthesis System.
  • In January 2021, Boston Scientific Corporation received FDA approval for its fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System used to treat symptoms in patients with advanced Parkinson's disease.

Key Takeaways from the Neuroprosthetics Market Report Study

  • Market size analysis for current Neuroprosthetics Market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the Neuroprosthetics market.
  • Various opportunities available for the other competitors in the Neuroprosthetics Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Neuroprosthetics market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Neuroprosthetics market growth in the coming future?

Target Audience who can be benefited from this Neuroprosthetics Market Report Study

  • Neuroprosthetics product providers
  • Research organizations and consulting companies
  • Neuroprosthetics related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Neuroprosthetics
  • Various end-users who want to know more about the Neuroprosthetics Market and the latest technological developments in the Neuroprosthetics Market.

Frequently Asked Questions for the Neuroprosthetics Market:

1. What are Neuroprosthetics?

  • A neuroprosthetic is a kind of device that can ameliorate the input or output of a neural system. Neuroprosthetics encompass a variety of artificial devices or systems that can be used to enhance the motor, sensory, cognitive, visual, auditory, and communicative deficits that arise from acquired brain injuries.

2. What is the market for Neuroprosthetics?

  • The Neuroprosthetics Market was valued at USD 7.14 billion in 2023, growing at a CAGR of 12.75% during the forecast period from 2024 to 2030 to reach USD 14.64 billion by 2030.

3. What are the drivers for the Neuroprosthetics market?

  • The neuroprosthetics market is slated to witness prosperity owing to factors such as the growing prevalence of neurological disorders and nerve injuries and the rising number of patients suffering from hearing and vision loss. Increasing R&D activities and collaborations to develop advanced devices among key players are the key factors that are responsible for contributing to the positive growth of the neuroprosthetics market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Neuroprosthetics market?

  • Some of the key market players operating in the neuroprosthetics market include Medtronic, Boston Scientific Corporation, Abbott Laboratories, NeuroPace, Inc., Cochlear Ltd., Sonova, NeuroSigma, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., MED-EL Medical Electronics, BrainGate, NEVRO CORP., Terumo Corporation, Penumbra, Inc., BrainCo, Inc., Axoft Inc., Demant A/S, Synapse Biomedical Inc., Cognixion, Inc., and others.

5. Which region has the highest share in the Neuroprosthetics market?

  • North America is expected to dominate the overall neuroprosthetics market during the forecast period from 2024 to 2030. This dominance can be attributed to the rising prevalence of hearing loss and neurological disorders such as Alzheimer's disease, Parkinson's disease, and depression. Additionally, increasing healthcare awareness and technological innovations spearheaded by leading industry players are significantly contributing to market growth in North America.

Table of Contents

1. Neuroprosthetics Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Neuroprosthetics Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Neuroprosthetics Market Key Factors Analysis

  • 5.1. Neuroprosthetics Market Drivers
    • 5.1.1. The growing prevalence of neurological disorders and nerve injuries
    • 5.1.2. Rising number of patients suffering from hearing and vision loss
    • 5.1.3. Increasing R&D activities and collaborations to develop advanced devices among key players
  • 5.2. Neuroprosthetics Market Restraints and Challenges
    • 5.2.1. The high cost of these devices
    • 5.2.2. Lack of proper training in poor developed countries
  • 5.3. Neuroprosthetics Market Opportunity
    • 5.3.1. Integration of robotic-assisted implantation
    • 5.3.2. Adoption of minimally invasive surgeries and smart implants

6. Neuroprosthetics Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Neuroprosthetics Market Assessment

  • 7.1. By Type
    • 7.1.1. Motor Prosthetics
    • 7.1.2. Cognitive Prosthetics
    • 7.1.3. Auditory Prosthetics/Cochlear Implants
    • 7.1.4. Visual Prosthetics/Retinal Implants
  • 7.2. By Procedure
    • 7.2.1. Invasive
    • 7.2.2. Non-Invasive
  • 7.3. By Technology
    • 7.3.1. Deep Brain Stimulation
    • 7.3.2. Vagus Nerve Stimulation
    • 7.3.3. Sacral Nerve Stimulation
    • 7.3.4. Spinal Cord Stimulation
    • 7.3.5. Transcranial Magnetic Stimulation
    • 7.3.6. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals and Clinics
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.2.5. Spain Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.3.3. India Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Neuroprosthetics Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Neuroprosthetics Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Neuroprosthetics Market Size In USD Million (2021-2030)

8. Neuroprosthetics Market Company and Product Profiles

  • 8.1. Medtronic
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Boston Scientific Corporation
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Abbott Laboratories
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. NeuroPace, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Cochlear Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Sonova
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. NeuroSigma, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Blackrock Neurotech
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Synchron
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. LivaNova, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. MED-EL Medical Electronics
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. BrainGate
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. NEVRO CORP.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Terumo Corporation
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Penumbra, Inc.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. BrainCo, Inc.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Axoft Inc.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Demant A/S
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Synapse Biomedical Inc.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Cognixion, Inc.
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Neuroprosthetics Market in Global (2021-2030)
  • Table 3: Neuroprosthetics Market in Global by Type (2021-2030)
  • Table 4: Neuroprosthetics Market in Global by Procedure (2021-2030)
  • Table 5: Neuroprosthetics Market in Global by Technology (2021-2030)
  • Table 6: Neuroprosthetics Market in Global by End-User (2021-2030)
  • Table 7: Neuroprosthetics Market in Global by Geography (2021-2030)
  • Table 8: Neuroprosthetics Market in North America (2021-2030)
  • Table 9: Neuroprosthetics Market in the United States (2021-2030)
  • Table 10: Neuroprosthetics Market in Canada (2021-2030)
  • Table 11: Neuroprosthetics Market in Mexico (2021-2030)
  • Table 12: Neuroprosthetics Market in Europe (2021-2030)
  • Table 13: Neuroprosthetics Market in France (2021-2030)
  • Table 14: Neuroprosthetics Market in Germany (2021-2030)
  • Table 15: Neuroprosthetics Market in United Kingdom (2021-2030)
  • Table 16: Neuroprosthetics Market in Italy (2021-2030)
  • Table 17: Neuroprosthetics Market in Spain (2021-2030)
  • Table 18: Neuroprosthetics Market in the Rest of Europe (2021-2030)
  • Table 19: Neuroprosthetics Market in Asia-Pacific (2021-2030)
  • Table 20: Neuroprosthetics Market in China (2021-2030)
  • Table 21: Neuroprosthetics Market in Japan (2021-2030)
  • Table 22: Neuroprosthetics Market in India (2021-2030)
  • Table 23: Neuroprosthetics Market in Australia (2021-2030)
  • Table 24: Neuroprosthetics Market in South Korea (2021-2030)
  • Table 25: Neuroprosthetics Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Neuroprosthetics Market in the Rest of the World (2021-2030)
  • Table 27: Neuroprosthetics Market in the Middle East (2021-2030)
  • Table 28: Neuroprosthetics Market in Africa (2021-2030)
  • Table 29: Neuroprosthetics Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Neuroprosthetics Market in Global (2021-2030)
  • Figure 3: Neuroprosthetics Market in Global by Type (2021-2030)
  • Figure 4: Neuroprosthetics Market in Global by Procedure (2021-2030)
  • Figure 5: Neuroprosthetics Market in Global by Technology (2021-2030)
  • Figure 6: Neuroprosthetics Market in Global by End-User (2021-2030)
  • Figure 7: Neuroprosthetics Market in Global by Geography (2021-2030)
  • Figure 8: Neuroprosthetics Market in North America (2021-2030)
  • Figure 9: Neuroprosthetics Market in the United States (2021-2030)
  • Figure 10: Neuroprosthetics Market in Canada (2021-2030)
  • Figure 11: Neuroprosthetics Market in Mexico (2021-2030)
  • Figure 12: Neuroprosthetics Market in Europe (2021-2030)
  • Figure 13: Neuroprosthetics Market in France (2021-2030)
  • Figure 14: Neuroprosthetics Market in Germany (2021-2030)
  • Figure 15: Neuroprosthetics Market in United Kingdom (2021-2030)
  • Figure 16: Neuroprosthetics Market in Italy (2021-2030)
  • Figure 17: Neuroprosthetics Market in Spain (2021-2030)
  • Figure 18: Neuroprosthetics Market in the Rest of Europe (2021-2030)
  • Figure 19: Neuroprosthetics Market in Asia-Pacific (2021-2030)
  • Figure 20: Neuroprosthetics Market in China (2021-2030)
  • Figure 21: Neuroprosthetics Market in Japan (2021-2030)
  • Figure 22: Neuroprosthetics Market in India (2021-2030)
  • Figure 23: Neuroprosthetics Market in Australia (2021-2030)
  • Figure 24: Neuroprosthetics Market in South Korea (2021-2030)
  • Figure 25: Neuroprosthetics Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Neuroprosthetics Market in the Rest of the World (2021-2030)
  • Figure 27: Neuroprosthetics Market in the Middle East (2021-2030)
  • Figure 28: Neuroprosthetics Market in Africa (2021-2030)
  • Figure 29: Neuroprosthetics Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Marker Opportunities
  • Figure 33: PORTER'S Five Force Analysis